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Identification of intracranial, atherosclerosis-related, large vessel occlusion (ICAS-LVO) is
important to set up an optimal endovascular treatment strategy, as most ICAS-LVOs
require specific endovascular modalities for efficient recanalization. However, there is
currently no decisive way to identify ICAS-LVO for endovascular treatment. Instead of
the few, non-specific, clinical and imaging findings that operators have depended on,
this review focused on the occlusion type, one of angiographical methods to identify the
ICAS-LVO. Occlusion type was originally devised for predicting procedural details and
endovascular outcomes of ICAS-LVO. Among occlusion types, truncal-type occlusion is
regarded as a surrogate marker for ICAS-LVO. Although rare, false positives or negatives
in truncal-type occlusion are possible. Nonetheless, occlusion type was easy to apply
and reliably predictive of procedural outcomes. Furthermore, occlusion type can be
determined prior to the procedure, which could allow it to be more helpful in setting
up an optimal strategy before starting endovascular treatment.
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INTRODUCTION
Mechanical thrombectomy has become a standard treatment for acute, intracranial, large vessel
occlusion (LVO) (1–3). Clinical outcomes of patients with an intracranial LVO have been
remarkably improved by mechanical thrombectomy, and an improved recanalization rate was one
of most important factors for these favorable outcomes (4). With modern endovascular devices
(e.g., stent retriever, contact aspiration thrombectomy), 70–90% successful recanalization rates
have been reported (5–9). Nevertheless, there are still a few problems with these devices. In
spite of high recanalization rates, 40% futile recanalization rates—patients whose functional status
is not independent—have been reported after endovascular treatment (EVT) (3, 10, 11). This
might be because patient outcome is also affected by many other clinical and procedural factors,
including time to recanalization, system of stroke care, and post-procedural management (12–14).
In this regard, one of the most important modifiable factors is to set up an optimal endovascular
strategy, because LVO can be effectively recanalized within a shorter timeframe using the optimal
endovascular strategy (9).
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Acute, intracranial, atherosclerosis-related LVO (ICAS-LVO)
is not rare (15). The reported frequency of ICAS-LVO in EVT-
eligible patients varies across studies, ranging from 5 to 36%
(16–28). More exactly, the frequency of ICAS-LVO depends on
the definition used and the patients’ ethnicities, locations of
occlusions, and eligible criteria for EVT (Table 1). In several
studies from Korea, ICAS-LVO was found in 12–30% of study
patients. Under the definition of significant fixed focal stenosis
(FFS), the frequency was about 15–20%, although the precise
definition was slightly variable across studies. Occlusion type,
one of the major definitions used for ICAS-LVOs, also showed
a similar range of frequencies, at about 12–18% (17, 18).
ICAS-LVO is known to be more frequent in the posterior
circulation (24, 32). In fact, one study reported that about 37%
of ICAS-LVOs were in the posterior circulation (22). Based
on angiographical determination, ICAS-LVOs seem to be less
frequent in Western studies, at about 5–8% of EVT-eligible
patients (19, 29).
Importantly, ICAS-LVO is considered a principal
reason for failure of modern endovascular thrombectomy
(17, 21, 23, 29). With modern endovascular modalities
(e.g., stent retriever, contact aspiration thrombectomy),
successful recanalization was possible in <30% of cases
of ICAS-LVO (17, 23). Thus, the feasibility and safety
of rescue endovascular modalities appropriate to ICAS-
LVO (e.g., balloon angioplasty, stenting, intra-arterial
glycoprotein IIb/IIIa inhibitor infusion) are constant points
of discussion (17, 20, 23, 26, 28, 30–36). Although there
is a lack of prospective studies regarding treatment of
ICAS-LVO, most reports have indicated that ICAS-specific
endovascular modalities are feasible in an acute setting. With
optimal use of ICAS-specific endovascular modalities, patient
outcome was also comparable to that of embolic occlusion
(16, 23, 28). Finally, the rapid introduction of ICAS-specific
endovascular modalities can be very important for timely and
successful recanalization.
Therefore, determination of ICAS-LVO seems essential and
critical for selecting an optimal endovascular treatment strategy.
However, disappointingly, there is no corroborant method
to identify ICAS-LVO. Such an identification method should
be reliable and show acceptable sensitivity and specificity.
It should be predictive of procedural details and applicable
during or before EVT to help operators establish an optimal
endovascular strategy. Some demographics, clinical risk factors,
and imaging findings have been reported to be associated
with ICAS-LVO (24, 32, 37–39). However, these demographics
and clinical risk factors might not be specific to ICAS-
LVO. Only atrial fibrillation proved to be fairly predictive
for endovascular outcomes and is a clinically used risk factor
(18, 24, 40). Although atrial fibrillation is associated with a
higher probability of embolic occlusion, this association might
be circumstantial (32). Certain imaging findings, such as a
hyperdense artery sign or blooming artifact, might be helpful
but are still controversial regarding role in the etiology of acute
LVO (37, 41).
Unlike those less-specific identification methods, ICAS-LVO
can be precisely identified angiographically (17, 32). Because
angiographical determination has been most widely used in
studies of ICAS-LVO, it is necessary to understand this method
in depth to develop optimal endovascular treatment strategies.
Among them, this review will discuss about the occlusion type—
one of methods to identify the ICAS-LVO based exclusively on
angiographical findings.
OCCLUSION TYPE
Occlusion type is one of the most reliable angiographical
surrogate markers for ICAS-LVO. Occlusion type was originally
devised to differentiate ICAS-LVO from an embolic occlusion
and was aimed for practical use in clinical settings (17). Before
the introduction of occlusion type, clinical, and radiological
findings (e.g., atrial fibrillation and hyperdense artery sign)
were considered to presume an embolic occlusion. Although
the concept of FFS was considered for similar purposes,
it was used as merely an operational definition for ICAS-
LVO and was not easy to apply during the procedure. More
importantly, the predictive value of FFS for modern mechanical
thrombectomy outcome has not been systemically evaluated
(23). In contrast, occlusion type on computed tomography
angiography (CTA) or digital subtraction angiography (DSA)
was well correlated with procedural outcomes, especially in stent
retriever thrombectomy (17, 18).
Significance of Occlusion Type
The theoretical background of occlusion type for identification of
ICAS-LVO is intuitive. For embolic occlusion, it is not likely for
an embolus to be spontaneously halted in the middle of a normal
artery. Instead, the embolus would likely become lodged at the
site of an arterial bifurcation (i.e., a branching-site occlusion,
BSO). In another words, an arterial occlusion found at the middle
of an artery (i.e., truncal-type occlusion, TTO) is likely not caused
by an embolus. In the narrow spectrum of occlusion etiologies of
LVO, the TTOmight be from an in situ thromboocclusion caused
by an underlying ICAS.
According to a study that evaluated this hypothesis, TTO
was significantly associated with stent retriever failure (odds
ratio (OR): 32.2; 95% confidence interval (CI): 7.78–133.0) and
with none of the embolic sources, such as cardioembolism
and artery-to-artery embolism (OR: 9.07; 95% CI: 3.74–22.0)
(17). Impressively, patients with a TTO showed a much
higher rate of reocclusion events than those with a BSO (77.3
vs. 5.0%; p < 0.001). Furthermore, most patients (78.9%)
eventually needed rescue modalities to achieve a successful
recanalization. It seems evident that the clinical and endovascular
details of TTOs are comparable to those of ICAS-LVO (16,
21, 23, 28, 29). Thus, in situations where no confirmative
identification method for ICAS-LVO is feasible during the
procedure, occlusion type could be a helpful surrogate marker to
identify ICAS-LVO.
The ultimate goal in determining occlusion type was to help
set up an optimal endovascular treatment strategy for ICAS-
LVO. Therefore, the previous study originally focused on the
predictive value of occlusion type for success of stent retrievers
and the necessity of rescue modalities specific to ICAS-LVO.
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TABLE 1 | Frequencies of intracranial atherosclerosis-related large vessel occlusion (ICAS-LVO) in endovascular treatment-eligible patients.
Study Definition of ICAS-LVO Nation of study
population
Anterior or posterior
circulation
Total number of
patients included
ICAS-LVO%
Matias-Guiu et al. (29) TOAST classification Spain Both 88 17.0
Kang et al. (30) Fixed focal stenosisa Korea Both 132 30.3
Gascou et al. (19) Intracranial stenosis France Both 144b 5.5
Al Kasab et al. (16) Significant fixed focal stenosis US Both 435 8.3
Lee et al. (24) Significant fixed focal stenosis Korea Both 158 15.2
Lee et al. (23) Significant fixed focal stenosis Korea Both 53c 17.0
Yi et al. (26) Significant fixed focal stenosis China Both 55 21.8
Yoon et al. (28) Significant fixed focal stenosis Korea Both 172 22.9
Jia et al. (20) Significant fixed focal stenosis China Anterior 140 34.0
Kim et al. (22) Significant fixed focal stenosis Korea Posterior 51d 37.3
Baek et al. (31) Truncal-type occlusion (by DSA) Korea Both 259 12.4
Baek et al. (18) Truncal-type occlusion (by CTA) Korea Both 238 18.1
a ICAS-LVO was identified by follow-up vascular imaging at 5–7 days.
bThis study included only patients treated with stent retrievers.
cThis study included only patients treated with stent retrievers as the first-line treatment modality.
dThis study included only patients treated primarily with mechanical thrombectomy.
TOAST, Trial of ORG 10172 in Acute Stroke Treatment; DSA, digital subtraction angiography; CTA, computed tomography angiography.
TABLE 2 | Angiographical findings suggestive of branching-site and truncal-type occlusions on catheter or digital subtraction angiography (DSA) and computed
tomography angiography (CTA).
Branching-site occlusion Truncal-type occlusion
Principle Involvement of the bifurcation site Intact bifurcation site and all distal major branches beyond occlusion
DSA (1) Failure of advancement of ACOM collateral flow to ipsilateral
MCAa (T-occlusion)
(2) Direct visualization of Y- or T-shaped filling defectb,c,d (Y- or
T-shaped clot)
(3) Absence or partial visualization of another branchd (branch-missing sign)
(1) Advancement of ACOM collateral flow to ipsilateral MCAa (below
T-occlusion)
(2) Clearly-visible distal major branches and bifurcation site beyond
occlusionb,c,d
CTA Vague or invisible major distal branches and bifurcation site beyond
occlusion
Clearly-visible distal major branches and bifurcation site beyond occlusion
aBy contralateral ICA angiogram.
bBy any angiography, including microcatheter angiography.
cBy minimal or partial recanalization using a thrombectomy procedure.
dBy post-deployment angiogram with stent-through flow.
ICA, internal carotid artery; ACOM, anterior communicating artery; MCA, middle cerebral artery.
Based on the predictability of stent retriever successfulness
in occlusion type, one could change endovascular modality
from stent retriever to other modalities specific to ICAS-
LVO earlier if TTO is observed. This strategy might avoid
unnecessary trials of stent retriever and shorten procedural
time. As for its practical application, occlusion type can be
easily determined during endovascular procedures. Especially,
in stent retriever thrombectomy, the occlusion type can be
determined by a single stent retriever deployment across the
occluded segment, as described in detail in the next section.
Furthermore, occlusion type can be reliably determined before
the endovascular procedure using preprocedural CTA (18). Early
determination of occlusion type might be helpful in setting
up the optimal endovascular treatment strategy. In addition,
the predictive value of CTA-determined occlusion type was
superior to atrial fibrillation or presence of a hyperdense
artery sign, which have previously been the most widely
considered pre-procedural identification methods, to presume
occlusion etiology.
Clinical outcomes according to occlusion type was reported
(42). In the single center report of 318 patients, the TTO
group showed a comparable recanalization rate with the BSO
group (80.4 vs. 88.5%; p = 0.097), although procedural details
were completely different. With the comparable recanalization
rate, clinical outcomes including favorable outcome (modified
Rankin Scale score at 3 months 0–2; 46.4 vs. 46.9%; p =
0.944), symptomatic intracranial hemorrhage, and mortality
were not significantly different between the TTO and the
BSO groups.
Determination of Occlusion Type During or
Before Endovascular Procedures
Occlusion type can be classified as either BSO or TTO during
endovascular procedures. For angiographical determination of
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FIGURE 1 | Determination of occlusion type by digital subtraction angiography (DSA) and computed tomography angiography (CTA). On contralateral internal
carotid artery (ICA) angiogram, collateral flow cannot advance to ipsilateral middle cerebral artery (MCA) through anterior communicating artery (ACOM) because
ipsilateral ICA bifurcation (ICBIF) site is involved in branching-site occlusion (A). On the contrary, collateral flow can progress to ipsilateral MCA in truncal-type
occlusion (H). In branching-site occlusion, Y- or T-shaped filling defect (clot) involving arterial bifurcation site can be observed on stent retriever deployment (B), on
microcatheter angiogram (C), or after minimal recanalization (D). In addition, owing to the involvement of arterial bifurcation site, only one branch that stent retriever is
deployed to can be seen on post-deployment angiogram in branching-site occlusion [arrow in (E–G)], while another branch is not seen [missing branch sign;
arrowhead in (E–G)]. In truncal-type occlusion, all major branches and its bifurcation site can be clearly observed by stent retriever deployment [(I,J); arrowhead, distal
markers of stent retriever], on microcatheter angiogram beyond occlusion, or after minimal recanalization (K). Those can also be observed on CTA images [(L–N);
arrow, original occlusion point]. ACA, anterior cerebral artery; M2, superior and inferior divisions of middle cerebral artery; MCBIF, middle cerebral artery bifurcation
site; BABIF, basilar artery bifurcation site.
BSO, the following findings can be considered (Table 2). First,
on contralateral internal carotid artery (ICA) angiography,
collateral flow through the anterior communicating artery
(ACOM) cannot advance to the ipsilateral middle cerebral artery
(MCA) if the ipsilateral ICA bifurcation site is involved, a
so-called ICA T-occlusion (BSO; Figure 1A). In contrast to
that, the collateral flow can advance further to the ipsilateral
MCA through the ACOM system if an occlusion is located
below the bifurcation site (TTO; Figure 1H). This finding
has been commonly observed at the start of endovascular
procedures during collateral evaluation. However, with the
recent push to shorten the time to recanalization, the target
vessel is treated without collateral assessment in most current
endovascular procedures.
Second, Y- or T-shaped filling defects involving the bifurcation
site can be directly observed during endovascular procedures by
microcatheter angiogram, after partial recanalization by minimal
thrombectomy procedure, or by angiogram performed with stent
retriever in deployment (Figures 1B–D). Without doubt, these
findings should be considered BSOs.
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FIGURE 2 | Angiographical territorial filling defect, suggestive of branching-site occlusion. On post-deployment angiogram during stent retriever thrombectomy,
branch-missing sign can be observed (A,B, arrowhead). In patients whose missing branch is vague, angiographical filling defect could be helpful to guess the
presence of the missing branch. On lateral view of post-deployment angiogram, corresponding territorial filling defect is seen (asterisk in C). On final angiogram, the
missing branch is obviously observed (D). ICA, internal carotid artery; MCA, middle cerebral artery; ACA, anterior cerebral artery.
TABLE 3 | Consistency of CTA- and DSA-determined occlusion type.
CTA-determined occlusion type
Branching-site
occlusion
Truncal-type
occlusion
DSA-determined occlusion type
Branching-site occlusion 182 (96.8%) 10 (24.4%)
Truncal-type occlusion 6 (3.2%) 31 (75.6%)
Total 188 41
This table was remade using the same study population in Baek et al. (18).
CTA, computed tomography angiography; DSA, catheter or digital subtraction
angiography.
Third, post-deployment angiography during stent retriever
thrombectomy could give useful hints as to the occlusion type.
For embolic occlusions in which an embolus might locate at
the bifurcation site, the stent-through blood might only flow
into the one branch where the stent retriever is deployed.
Consequently, post-deployment angiography shows only one of
all of the major branches (i.e., branch-missing sign, implicating
BSO; Figures 1E–G). An angiographical territorial filling defect
could be an indirect finding for the absence of the other major
branches (Figure 2). If an occlusion is located at the arterial
trunk, all major distal branches can be clearly seen by stent-
through blood flow (TTO; Figures 1I,J).
To define the TTO, one should confirm that a bifurcation
site and all its major distal branches are intact (distal
confirmation). This distal confirmation can be performed
by evaluating collateral flow through the ACOM system,
microcatheter angiography beyond the occlusion site, stent-
through blood flow across the occlusion site, or achievement
of minimal recanalization (Figure 1K). More importantly, distal
confirmation is also possible by CTA, which is more intuitive
and easier than using catheter angiography or DSA (Table 2 and
Figures 1L–N). In fact, its interrater agreement for classifying
occlusion type was higher than that of DSA (kappa value 0.96 vs.
0.89) (18).
Concerns With Regard to Occlusion Type
Disadvantages and Advantages in Determining
Occlusion Type by DSA
Occlusion type is practically significant, is informative to set
up an endovascular strategy, and is simpler to apply than
FFS. In spite of these advantages, using DSA-determined
occlusion type for identifying ICAS-LVOs has a few limitations.
Above all, some additional manipulations are required for
determination of occlusion type—for example, contralateral
ICA angiography, microcatheter angiography beyond the
occlusion, or post-deployment angiography. Among them,
most determination practically depends on stent-through
blood flow. Therefore, occlusion type often cannot be
determined by DSA in patients who undergo non-stent
retriever thrombectomy (e.g., contact aspiration thrombectomy),
who did not have post-deployment angiography, or in whom
stent-through blood flow was not achieved. In practice,
occlusion type could not be determined by DSA in about
3.8% of patients (18). However, CTA findings are still helpful
in those cases whose occlusion type cannot be determined
by DSA.
One of most important advantages of occlusion type is
that it is not affected by treatment results. In contrast with
FFS, occlusion type can be determined even in cases of
persistent occlusion or incomplete recanalization. Furthermore,
occlusion type is obviously unaffected by the remnants of emboli,
vasospasm, and iatrogenic artery dissection.
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TABLE 4 | Summary of 10 patients who had CTA-determined truncal-type occlusion and DSA-determined branching-site occlusion (CTA-TTO with DSA-BSO).
Occlusion site AF Reocclusion mTICI AOL Recanalization modality DSA findings suggestive of initial TTO
1 ICA + – 2a 3 Stent retriever None
2 MCA – – 2b 3 Stent retriever None
3 ICA + – 2b 3 Stent retriever Huge clot halted in cervical ICA
4 ICA + – 3 3 Stent retriever Huge clot halted in cervical ICA
5 ICA + – 0 0 N/A Huge clot halted in cervical ICA
6 ICA + – 0 0 N/A None
7 ICA – – 2b 3 Stent retriever Huge clot halted in cervical ICA
8 ICA + – 3 3 Stent retriever Huge clot halted in cervical ICA
9 BA – + 3 3 Stent retriever for distal BA; PTA with
stenting and GPI for BA trunk
Fixed focal stenosis in the BA trunk (as a
tandem lesion)
10 ICA + – 2b 3 Stent retriever None
CTA, computed tomography angiography; DSA, catheter or digital subtraction angiography; AF, atrial fibrillation; mTICI, modified thrombolysis in cerebral infarction; AOL, arterial occlusive
lesion; ICA, internal carotid artery; MCA, middle cerebral artery; BA, basilar artery; PTA, percutaneous transluminal angioplasty; GPI, glycoprotein IIb/IIIa inhibitor.
False Positives in TTO Determination by CTA
(CTA-TTO With DSA-BSO)
Although CTA can be useful for identifying occlusion type,
there is still the problem of false classification. DSA- and CTA-
determined occlusion types can contradict each other. CTA-
determined occlusion type was not in agreement with DSA-
determined occlusion type in about 7.0% of patients (Table 3)
(18). Among them, quite a few cases (62.5%, 10 of 16) had a
DSA-determined BSO that was originally classified as a TTO on
preprocedural CTA. One possible mechanism for this change in
occlusion type is that distal migration of the clot which halted
in the arterial trunk. In fact, half of these patients had a huge
clot in the arterial trunk on DSA, which was observed as an
angiographical filling defect (Table 4). Their original occlusion
might have been a TTO in which the clot halted in the arterial
trunk. However, on DSA, in addition to these clots in the
arterial trunk, a distal BSO was also newly found. This finding
is suggestive of distal migration of a proximal clot that halted
in the arterial trunk to its distal bifurcation site, which finally
led to the formation of a new, distal BSO that was not seen
on preprocedural CTA. Similarly, in patient with BA occlusion,
a new distal BSO might develop as a result of an artery-to-
artery embolism from an ICAS-related lesion in the BA trunk.
New distal BSOs were completely recanalized by stent retriever
without residual stenosis in almost all cases. Although a few
patients did not have a “truncal embolus” on DSA, complete
distal migration of a proximal clot is a possible mechanism, in
the same manner as described above.
It remains unclear why an embolus would halt in the middle
of an artery. In those patients, the arteries did not show any
morphological abnormalities that would explain why an embolus
could be caught. Instead, we hypothesize that it might relate to
the size of the embolus—a very large embolus might become
compacted and ultimately lodged in the tortuous but not stenotic
middle trunk of an artery (e.g., cavernous segment of internal
carotid artery). Also, hemodynamic flow competition forces can
affect the migration of emboli. For example, if a patient had
sufficiently strong collateral flow through the ACOM to elicit
effective retrograde flow, it might be possible for an embolus to
not advance to its bifurcation site. In fact, in these patients, most
truncal emboli were found in the cervical or petro-cavernous
segment of ICA, in whom ACOM is quite thick and therefore
cross collateral flows are sufficiently strong (Table 4).
False Negatives in TTO Determination by CTA
(CTA-BSO With DSA-TTO)
Distal confirmation in CTA is dependent on visualization of a
distal part of the artery beyond the occlusion. Because contrast
media should reach the distal part of the artery beyond the
occlusion, collateral flow is important in determining occlusion
type by CTA. Collateral flow through the communicating arteries
is important for distal confirmation in ICA or basilar artery
occlusion. On the contrary, in MCA occlusion, leptomeningeal
collateral flow, which shows greater individual differences,
is important. Thus, CTA can misclassify truncal-type MCA
occlusion as BSO if a patient has poor leptomeningeal collaterals
to the MCA area. In fact, about 3.2% of CTA-determined BSOs
were actually found to be TTOs on DSA (Table 3). Expectedly,
all of these cases were MCA occlusions.
Given this, CTA-determined occlusion type, which showed
a higher sensitivity for detecting the BSO compared to TTO,
might be slightly biased toward identifying BSO. This limitation
could be overcome by using multiphase CTA, which can allow
for sufficient time for retrograde filling of contrast media into the
distal part of the artery.
CONCLUSIONS
Among only a few identification methods, the ICAS-LVO can be
feasibly identified by angiographical findings. The identification
of ICAS-LVO based on based on occlusion type, is a reliable and
practical identificationmethod for ICAS-LVO. Procedural details
by occlusion type and its predictability to endovascular results
were reported. Furthermore, occlusion type can be determined
before or in the early stages of the procedure, which may be most
helpful in setting up an optimal endovascular treatment strategy.
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